E07.1 Dyshormogenetic goiter

Name of the Condition

• Dyshormogenetic Goiter (ICD-10 Code: E07.1)
  
  • Also known as: Dyshormonogenetic goiter.

Summary

Dyshormogenetic goiter is a type of goiter resulting from defects in thyroid hormone synthesis, leading to impaired thyroid function. This condition is typically due to genetic mutations affecting enzymes or proteins involved in thyroid hormone production, causing the thyroid gland to enlarge as it attempts to compensate for reduced hormone output.

Causes

The condition arises from genetic mutations that disrupt the biochemical pathways required for thyroid hormone synthesis. These mutations may affect enzymes such as thyroid peroxidase, thyroglobulin, or other components involved in iodine organification, coupling, or hormone release. The resulting defect impairs the thyroid's ability to produce sufficient hormones, triggering compensatory growth of the gland.

Risk Factors

• Family history of congenital hypothyroidism or thyroid hormone synthesis defects.
• Inherited genetic mutations affecting thyroid function.
• Consanguinity (increased risk of autosomal recessive inheritance).

Symptoms

• Enlarged thyroid gland (goiter), often visible as neck swelling.
• Symptoms of hypothyroidism, such as fatigue, weight gain, cold intolerance, or sluggishness.
• In some cases, goiter may cause local pressure symptoms (e.g., difficulty swallowing or breathing if enlarged).

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests typically show low levels of thyroid hormones (T4) with elevated thyroid-stimulating hormone (TSH). Thyroid ultrasound may reveal an enlarged gland with heterogeneous texture. Genetic testing can confirm specific mutations if suspected.

Treatment Options

• Thyroid hormone replacement therapy: Levothyroxine is commonly used to normalize hormone levels and reduce goiter size.
• Iodine supplementation: May be considered if iodine deficiency contributes to the condition.
• Surgical intervention: Rarely required, but may be necessary for large goiters causing compressive symptoms.

Prognosis and Follow-Up

With appropriate treatment, prognosis is generally good, and most individuals achieve normal thyroid function. Regular follow-up is essential to monitor hormone levels and adjust therapy as needed. Lifelong management may be required, especially if genetic mutations are confirmed.

Complications

• Persistent hypothyroidism if untreated.
• Goiter enlargement leading to airway or esophageal compression.
• Developmental delays in untreated infants or children.

Lifestyle & Prevention

• Ensure adequate iodine intake through diet (e.g., iodized salt, seafood) to support thyroid function.
• Genetic counseling for families with a history of thyroid synthesis defects.
• Regular medical check-ups for early detection and management.

When to Seek Professional Help

Seek medical attention if you experience unexplained neck swelling, persistent fatigue, weight changes, or symptoms of hypothyroidism. Prompt evaluation is critical for infants or children with suspected thyroid dysfunction.

Tips for Medical Coders

• Use E07.1 for dyshormogenetic goiter, ensuring documentation supports the diagnosis (e.g., genetic testing, hormone levels, or imaging findings).
• Differentiate from other goiter types (e.g., endemic or sporadic) by verifying the underlying cause in clinical records.
• Confirm that the code aligns with the patient's specific thyroid hormone synthesis defect, as documented by the provider.